Abstract

Dry Powders for Pulmonary Delivery of Peptides and Proteins

Highlights

  • Recent advances in biotechnology have made it possible to use macromolecules such as peptides and proteins as therapeutic agents

  • This section summarizes the histological features of the lungs, drug permeability through the lung epithelium, the metabolism of proteins and peptides in lung tissue, and the safety of peptides and proteins administered through the lungs

  • These results suggest that drug absorption is more rapid in the alveolar region than in the tracheobronchial region of the lungs [24]

Read more

Summary

Introduction

Recent advances in biotechnology have made it possible to use macromolecules such as peptides and proteins as therapeutic agents. At this time intravenous, intramuscular, and subcutaneous injections are the practical routes for administering such macromolecules. Recombinant human deoxyribonuclease (rhDNase) is the first protein approved for inhalation therapy [1]. This review will focus on the dry powder peptides and proteins for inhalation. The success of inhalation therapy with dry powders is determined by the active ingredient’s biological aspects, by the physicochemical aspects of formulation, and by inhaler performance (Fig. 1). Factors determining successful inhalation therapy with dry powders. Biological and physicochemical aspects of inhalation therapy with dry powder peptides and proteins. Extensive reviews on inhalers are available elsewhere [8, 9]

Biological aspects of the pulmonar y absorption of peptides and proteins
Histological features of the lungs
Drug absorption through the lungs
Metabolism in the lungs
Safety of inhaled proteins
Additives for improving bioavailability of inhaled peptides and proteins
Physical aspects of dr y powder peptides and proteins
Spray dr y for preparation of dr y powder peptides and proteins
Application of supercritical fluids to preparation of dr y powder proteins
Stability of peptides and proteins
Mass median aerodynamic diameter
Hollow porous particles
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.